This information was published on 2026-02-23T11:32:45 for IP Right Registration Published.
| Field | Value |
| (210) | 2610813 |
| (220) |
10 Dec 2025
|
| (300) |
US, 11 Jun 2025, 99228661
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations. |
| (540) | STRYZACTA |
| (550) | Word |
| (730) |
RayzeBio, Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.